Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Human Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.7% during the forecast period.
This report presents the market size and development trends by detailing the Human Vaccines market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Human Vaccines market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Human Vaccines industry and will help you to build a panoramic view of the industrial development.
Human Vaccines Market, By Type:
Pneumococcal
Influenza
Hepatitis
HPV
Meningococcal
Rotavirus
Measles
Typhoid
Combination
Human Vaccines Market, By Application:
Pediatrics
Adolescents
Adults
Geriatrics
Some of the leading players are as follows:
Mitsubishi Tanabe Pharma
Takeda Pharmaceutical Company Limited.
Johnson & Johnson
Biological E Limited
CSL Limited
GlaxoSmithKline plc
Valneva, Inc.
Shenzhen Kangtai Biological Products Co., Ltd.
Mymetics
Sanofi
Novartis AG
Sinovac
Seqirus & Co., Inc.
Emergent BioSolutions, Inc.
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Human Vaccines Market: Technology Type Analysis
-
4.1 Human Vaccines Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Human Vaccines Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Pneumococcal
4.3.2 Influenza
4.3.3 Hepatitis
4.3.4 HPV
4.3.5 Meningococcal
4.3.6 Rotavirus
4.3.7 Measles
4.3.8 Typhoid
4.3.9 Combination
5 Human Vaccines Market: Product Analysis
-
5.1 Human Vaccines Product Market Share Analysis, 2018 & 2026
-
5.2 Human Vaccines Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Human Vaccines Market: Application Analysis
-
6.1 Human Vaccines Application Market Share Analysis, 2018 & 2026
-
6.2 Human Vaccines Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Pediatrics
6.3.2 Adolescents
6.3.3 Adults
6.3.4 Geriatrics
7 Human Vaccines Market: Regional Analysis
-
7.1 Human Vaccines Regional Market Share Analysis, 2018 & 2026
-
7.2 Human Vaccines Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Mitsubishi Tanabe Pharma
9.1.1 Mitsubishi Tanabe Pharma Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Takeda Pharmaceutical Company Limited.
9.2.1 Takeda Pharmaceutical Company Limited. Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Johnson & Johnson
9.3.1 Johnson & Johnson Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Biological E Limited
9.4.1 Biological E Limited Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 CSL Limited
9.5.1 CSL Limited Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 GlaxoSmithKline plc
9.6.1 GlaxoSmithKline plc Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Valneva, Inc.
9.7.1 Valneva, Inc. Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Shenzhen Kangtai Biological Products Co., Ltd.
9.8.1 Shenzhen Kangtai Biological Products Co., Ltd. Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Mymetics
9.9.1 Mymetics Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Sanofi
9.10.1 Sanofi Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Novartis AG
9.11.1 Novartis AG Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Sinovac
9.12.1 Sinovac Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Seqirus & Co., Inc.
9.13.1 Seqirus & Co., Inc. Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Emergent BioSolutions, Inc.
9.14.1 Emergent BioSolutions, Inc. Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
The List of Tables and Figures (Totals 108 Figures and 134 Tables)
Figure Pneumococcal Human Vaccines market, 2015 - 2026 (USD Million)
Figure Influenza Human Vaccines market, 2015 - 2026 (USD Million)
Figure Hepatitis Human Vaccines market, 2015 - 2026 (USD Million)
Figure HPV Human Vaccines market, 2015 - 2026 (USD Million)
Figure Meningococcal Human Vaccines market, 2015 - 2026 (USD Million)
Figure Rotavirus Human Vaccines market, 2015 - 2026 (USD Million)
Figure Measles Human Vaccines market, 2015 - 2026 (USD Million)
Figure Typhoid Human Vaccines market, 2015 - 2026 (USD Million)
Figure Combination Human Vaccines market, 2015 - 2026 (USD Million)
Figure Pediatrics market, 2015 - 2026 (USD Million)
Figure Adolescents market, 2015 - 2026 (USD Million)
Figure Adults market, 2015 - 2026 (USD Million)
Figure Geriatrics market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Human Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table North America Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table North America Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table North America Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Canada Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Canada Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Europe Human Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table Europe Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Europe Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Europe Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Germany Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Germany Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table France Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table France Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Italy Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Italy Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Spain Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Spain Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Human Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table China Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table China Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Japan Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Japan Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table India Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table India Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Human Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table MEA Human Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table MEA Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table MEA Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table MEA Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Human Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Human Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Human Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Mitsubishi Tanabe Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Takeda Pharmaceutical Company Limited. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biological E Limited Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CSL Limited Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline plc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Valneva, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shenzhen Kangtai Biological Products Co., Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mymetics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sinovac Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Seqirus & Co., Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Emergent BioSolutions, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
